Nick Jones
LightNews LightNews
nickhuwjones.bsky.social
Nick Jones
@nickhuwjones.bsky.social
260 followers 190 following 35 posts
Research policy @ Cancer Research UK. Trying to unlock the potential of science and data to transform cancer outcomes.
Posts Replies Media Videos
nickhuwjones.bsky.social
Picture makes me fondly remember when a sector letter pushing back on possible R&D cuts was written up with this wonderfully evocative image...
July 16, 2025 at 3:14 PM
nickhuwjones.bsky.social
London could use the productivity uplift tbf (as per Centre for Cities Outlook 2025)
February 14, 2025 at 4:30 PM
nickhuwjones.bsky.social
Letter from the Lords S&T committee to the Home Sec and Chancellor today. We're in a global competition for talent in science and technology - the UK’s visa and immigration policy needs to adapt.

Great to see CRUK analysis feature heavily.

committees.parliament.uk/publications...
February 4, 2025 at 11:09 AM
nickhuwjones.bsky.social
The power of collaboration on display! And as outlined by the Minister's below, a perfect example of how cutting edge, data driven research can deliver the Govt's health and growth missions, through earlier diagnosis, better prevention, and increased productivity.
January 22, 2025 at 9:57 AM
nickhuwjones.bsky.social
The transformation in UK lung cancer R&D in the last decade has been extraordinary - from stagnant investment and a fragmented community, to some of the most exciting science in cancer research. As Govt aims to leverage R&D for their missions, they should look at the principles that guided this:
What can Government learn from this? There are clear transferable lessons to be learnt from our experience in supporting the UK lung cancer research ecosystem. Clear diagnosis of the problem: Through our strategy process, we identified the weaknesses in the lung cancer research ecosystem – and set ourselves on the path to tackle them. Without taking time to make a clear diagnosis of the barriers to achieving your mission, you cannot strategically target investment and galvanise partners around the solutions. Time and patience: To deliver on the ambition a mission sets, it must be backed by long-term sustained investment, at scale. In lung cancer this sustained investment has been central in building and maintaining the communities, connections and leadership that are driving the change we needed. Clear evaluation: By taking a data-driven approach supported by expert review, and committing to act on what the evaluation says, you ensure that energy and investment is still centred around your objectives, and that resources are invested where they have the most potential for impact. Partnership: Collaboration is at the heart of our mission-driven approach, ensuring that the impact of our funding is greater than the sum of its parts. International partnerships such as Cancer Grand Challenges enable global, interdisciplinary teams to take on the toughest challenges in cancer, while collaborations with industry such as those we foster through Cancer Research Horizons are critical to harness the translational power needed to bring progress to patients.
January 16, 2025 at 9:38 AM